Skip to content
DeepViews

Canopy Growth Corporation Common Shares (CGC) — 分析摘要

Canopy Growth Corporation Common Shares(CGC)的市值为320.45百万美元,最近一年的营收同比增长了+6.9%。净利润率为-92.4%。当前市盈率为-1.7倍。

核心要点

  • 营收同比变化+6.9%
  • 净利润率-92.4%
  • 市盈率-1.7倍

与MEDICINAL CHEMICALS & BOTANICAL PRODUCTS板块的其他公司相比,CGC的营收增长为+6.9%,市盈率为-1.7倍。

[XNAS]

Canopy Growth Corporation Common Shares (CGC)

$0.76

前收盘价 2026-10-12 · 市场数据 POLYGON · 财务数据 SEC EDGAR

市值
$320.45M
企业价值
$226.21M
市盈率
-1.7
股息率
126.73%
EV/EBITDA
-2.2
公司简介
关于
关于 Canopy Growth Corporation Common Shares

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

行业

MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

员工人数

1,128

总部

SMITH FALLS, A6

Exchange

XNAS

官网
Source: Polygon.io
评分
竞争壁垒
竞争壁垒
29
无护城河

基于 4 年财务数据的系统性竞争优势评估

此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。

市场信号
估值
盈利
内部人交易
内部人备案活动

首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。

加载 SEC 内部人备案数据...
超级投资者
财务健康
财务健康

资本结构

总权益$500.61M
总债务$167.46M
债务权益比0.33
现金及等价物$261.70M

现金流

经营现金流$-46.22M
自由现金流$-50.08M
自由现金流率-24.29%
P/FCF 比率-6.40
Source: Polygon.io · SEC EDGAR
股息
股息

年度每股股息

$0.96

股息收益率

126.73%

季度
最近除息日: 2007-08-01

股息历史

2007-08-01
CD$0.2400
2007-04-26
CD$0.2400
2007-01-29
CD$0.2400
2006-10-27
CD$0.2400
Source: Polygon.io
最新资讯
Recent News

免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。